Sign in

CIK 0001393434

  • Large accelerated filer

OCULAR THERAPEUTIX, INC

Sign in to watch
Ticker
OCUL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 781-357-4000
Business address
14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
Former names
I-THERAPEUTIX INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$799,174
in 9 filings, $788K under 10b5-1 plans

Net −$799,174. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 8 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-03 Goldstein Michael H. President, Ophthalmology & CMO Grant or award +63,333 313,335
2022-02-03 Goldstein Michael H. President, Ophthalmology & CMO Grant or award · Stock Option (Right to Buy) +190,000 190,000
2021-02-17 Goldstein Michael H. President, Ophthalmology & CMO Grant or award · Stock Option (Right to Buy) +250,000 250,000
2020-01-30 Goldstein Michael H. Chief Medical Officer Grant or award · Stock Option (Right to Buy) +215,000 215,000
2019-05-28 Goldstein Michael H. Chief Medical Officer Purchase +12,000 $2.51 $30K 25,686
2019-03-15 Goldstein Michael H. Chief Medical Officer Purchase +10,000 $4.15 $42K 13,686
2019-01-02 Goldstein Michael H. Chief Medical Officer Grant or award · Stock Option (Right to Buy) +150,000 150,000
2018-01-31 Goldstein Michael H. Chief Medical Officer Grant or award · Stock Option (Right to Buy) +83,500 83,500
2017-10-02 Goldstein Michael H. Chief Medical Officer Grant or award · Stock Option (Right to Buy) +135,000 135,000

Page 1 of 1 · 9 trades